Literature DB >> 7445065

Pitfalls of salicylhydroxamic acid plus glycerol treatment of T. vivax infected goats.

C van der Meer, J A Versluys-Broers, C T van Duin, T S van den Ingh, J Nieuwenhuijs, D Zwart.   

Abstract

A dosage regime of SHAM (260 to 355 mg/kg) plus glycerol (890 to 1216 mg/kg), cleared T. vivax from peripheral blood of infected goats. Relapses occurred on two occasions in one goat and death during infusion of the drug in two other goats. Pharmacokinetic studies showed that both SHAM and glycerol are rapidly eliminated, the elimination possibly being slower in infected than in uninfected goats. For this reason and also because of the poor solubility of SHAM, very large volumes (500-1000 ml) had to be infused intravenously to obtain therapeutic plasma concentrations. The difficulties of adjusting the pH, the large volumes to be injected combined with the narrow margin between therapeutic and lethal dose preclude practical application of this form of treatment. Toxicity became apparent as a marked increase in heart rate and cessation of the ruminal movements which lasted for about 6 hours. A Herxheimer reaction may play an additional role in infected goats. Relapses may be due either to the fact that the levels of the drugs in the tissue were too low, or to the presence of a sub-population of T. vivax which is not susceptible to the treatment with SHAM plus glycerol.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7445065

Source DB:  PubMed          Journal:  Tropenmed Parasitol        ISSN: 0303-4208


  3 in total

1.  Roles of triosephosphate isomerase and aerobic metabolism in Trypanosoma brucei.

Authors:  S Helfert; A M Estévez; B Bakker; P Michels; C Clayton
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

2.  Observations on salicyl hydroxamic acid, an experimental trypanocide.

Authors:  A J Barnicoat; W G van't Hoff; P J Morrison; H J Rogers
Journal:  Experientia       Date:  1981-12-15

3.  QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach.

Authors:  Alicia Rosell-Hidalgo; Luke Young; Anthony L Moore; Taravat Ghafourian
Journal:  J Comput Aided Mol Des       Date:  2020-12-08       Impact factor: 3.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.